CD8A and hepatocellular carcinoma: In conclusion, our findings indicated that BBR prevented the progression of HCC through regulating the heterogeneity of intrahepatic T lymphocytes, which involves increasing the proportion of central memory CD8+ T cells while decreasing effector CD8+ T cells to reverse T cell exhaustion.